N

Minerva Neurosciences
D

NERV

1.88000
USD
0.06
(3.30%)
مغلق
حجم التداول
0
الربح لكل سهم
-3
العائد الربحي
-
P/E
-4
حجم السوق
13,147,603
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ACAD
    -0.350
    (-1.73%)
    19.940 USD
    B
    BMRN
    -0.525
    (-0.76%)
    68.215 USD
    E
    ESPR
    -0.03500
    (-1.88%)
    1.82500 USD
    I
    IONS
    -0.365
    (-1.12%)
    32.310 USD
    S
    SAGE
    0.16000
    (2.24%)
    7.30500 USD
    S
    SRPT
    -2.010
    (-1.86%)
    106.280 USD
    المزيد
الأخبار
المقالات

العنوان: Minerva Neurosciences

القطاع: Healthcare
الصناعة: Biotechnology
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.